联合PD-1/L1免疫检查点抑制剂方案用于EGFR-TKIs耐药后晚期非小细胞肺癌的疗效分析
葛建娟, 施向荣, 周艳, 谭清和, 李剑英
Efficacy analysis of the combined PD-1/L1 immune checkpoint inhibitor regimen for advanced non-small cell lung cancer after EGFR TKIs resistance
GE Jianjuan, SHI Xiangrong, ZHOU Yan, TAN Qinghe, LI Jianying
广州医药
.
2024, (12): 1437
-1443
.
DOI: 10.20223/j.cnki.1000-8535.2024.12.008
